The South African strain of the corona virus poses a new challenge
Scientific research has claimed that the South African strain of the coronavirus could reduce the protective effects of the Pfizer vaccine, a discovery that has raised new concerns.
Earlier, the AstraZeneca vaccine was considered weak against a new strain of coronavirus found in South Africa, and now the Pfizer vaccine has been shown to be less effective. Research has shown that Pfizer, a new type of pandemic, is a less effective vaccine.
Research has shown that the South African type of vaccine significantly reduces the effectiveness of protective antibodies. Evidence is being gathered. So far nothing can be said.
The study was conducted by scientists at the University of Texas Medical Branch, who tested a new type of cornvirus in a laboratory and tried to evaluate the effects of existing vaccines.
Studies have shown that after the use of the vaccine, the level of antibodies against this new strain is reduced by two-thirds compared to the old strain. The study was published in the New England Journal of Medicine.
The researchers also said that despite the lack of antibodies, the Pfizer vaccine could provide protection against the virus.